EX-23.1 4 v163496_ex23-1.htm
EXHIBIT 23.1.
 
Consent of Independent Registered Public Accounting Firm
 
Generex Biotechnology Corporation
Toronto, Ontario
 
We consent to the incorporation by reference in this Post Effective Amendment No. 1 to Registration Statement No. 333-145412 on Form S-8 of our report dated October 6, 2009 relating to the consolidated financial statements and Schedule II included in the Annual Report of Generex Biotechnology Corporation on Form 10-K for the year ended July 31, 2009.
 
/s/ MSCM LLP
MSCM LLP
Toronto, Canada

October 21, 2009